WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010033466) MACROCYCLIC INHIBITORS OF HEPATITIS C PROTEASE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/033466    International Application No.:    PCT/US2009/056859
Publication Date: 25.03.2010 International Filing Date: 14.09.2009
IPC:
A01N 55/02 (2006.01), A61K 31/47 (2006.01), A61K 31/555 (2006.01)
Applicants: PHENOMIX CORPORATION [US/US]; 5930 Cornerstone Court West, Suite 230 San Diego, California 92121 (US) (For All Designated States Except US).
BETANCORT, Juan Manuel [ES/US]; (US) (For US Only).
HEPPERLE, Michael E. [US/CH]; (CH) (For US Only).
CAMPBELL, David Alan [US/US]; (US) (For US Only).
WINN, David T. [US/US]; (US) (For US Only)
Inventors: BETANCORT, Juan Manuel; (US).
HEPPERLE, Michael E.; (CH).
CAMPBELL, David Alan; (US).
WINN, David T.; (US)
Agent: PERDOK SHONKA, Monique M., USPTO Reg. No. 42,989; Schwegman, Lundberg & Woessner, P.A. P.O. Box 2938 Minneapolis, Minnesota 55402 (US)
Priority Data:
61/097,414 16.09.2008 US
Title (EN) MACROCYCLIC INHIBITORS OF HEPATITIS C PROTEASE
(FR) INHIBITEURS MACROCYCLIQUES DE LA PROTÉASE DU VIRUS DE L'HÉPATITE C
Abstract: front page image
(EN)The invention provides macrocyclic compounds inhibitory to the Hepatitis C viral protease, compositions and combinations including the compounds, methods of treatment of conditions wherein inhibition of the Hepatitis C viral protease is medically indicated, and methods of treatment of a Hepatitis C viral infection in a human patient.
(FR)Cette invention concerne des composés macrocycliques inhibant la protéase du virus de l'hépatite C, des compositions et des combinaisons contenant ces composés, des méthodes de traitement de pathologies dans lesquelles l'inhibition de la protéase du virus de l'hépatite C est indiquée du point de vue médical, et des méthodes de traitement d'une infection par le virus de l'hépatite C chez l'homme.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)